Examkin

Question

Difficulty: HardPreventive Care and Screening

A 61-year-old postmenopausal woman presents to the ambulatory clinic for an annual wellness visit. She has not seen a physician in three years. Medical history is significant for mild hypertension and gastroesophageal reflux disease. Current medications include amlodipine and pantoprazole. Social history is notable for smoking 10 cigarettes a day (25-pack-year history) and drinking 1-2 glasses of wine on weekends. Her mother suffered a femoral neck fracture at age 76. Her preventive care history includes a normal screening mammogram and normal cervical cytology with human papillomavirus (HPV) co-testing one month ago at a health fair. Her last screening colonoscopy was normal at age 55. Physical examination reveals a blood pressure of 128/82 mm Hg, heart rate of 72/min, and a body mass index (BMI) of 22 kg/m². The remainder of the examination is unremarkable. The patient asks if she should be tested for osteoporosis. According to current guidelines, which of the following is the most appropriate next step regarding osteoporosis screening for this patient?

  1. A
    Order dual-energy x-ray absorptiometry (DEXA)
  2. Calculate fracture risk using a formal clinical risk assessment toolAnswer
  3. C
    Reassure her and recommend initiating DEXA screening at age 65
  4. D
    Obtain baseline serum calcium, phosphorus, and 25-hydroxyvitamin D levels
  5. E
    Advise starting prophylactic oral bisphosphonate therapy

Answer

Calculate fracture risk using a formal clinical risk assessment tool
The United States Preventive Services Task Force (USPSTF) recommends screening for osteoporosis with bone measurement testing (e.g., DEXA) in all women aged 65 and older. For postmenopausal women younger than 65, screening is indicated only if they are at increased risk for osteoporotic fractures. Crucially, this risk must be determined using a formal clinical risk assessment tool, such as the Fracture Risk Assessment Tool (FRAX), the Osteoporosis Risk Assessment Instrument (ORAI), or the Osteoporosis Self-Assessment Tool (OST). This patient has multiple risk factors (smoking, parental hip fracture, lower BMI), but the evidence-based next step is to quantify her risk using a validated tool to see if it meets the screening threshold (equivalent to the risk of a 65-year-old white woman without major risk factors, which is approximately 8.4%). Only if her calculated risk meets or exceeds this threshold should a DEXA scan be ordered.

Step-by-Step Solution

1
Assess the patient's demographic and menopausal status
The patient is a 61-year-old postmenopausal woman.
Osteoporosis screening guidelines differ significantly based on whether a woman is over or under the age of 65.
2
Identify relevant clinical risk factors for osteoporosis
Risk factors include current smoking, parental history of hip fracture, lower body mass index (22 kg/m²), and chronic proton pump inhibitor use (pantoprazole).
The presence of clinical risk factors in a woman under 65 indicates a potential need for earlier screening.
3
Apply the USPSTF screening guidelines for women under 65 years of age
Guidelines recommend screening postmenopausal women under 65 only if their 10-year fracture risk meets or exceeds 8.4%, which must be calculated by a formal clinical risk assessment tool.
A formal tool (e.g., FRAX) must be used to objectively quantify risk before proceeding with bone measurement testing.

Key Concept

In postmenopausal women younger than 65 years, osteoporosis screening with DEXA is indicated only if a formal clinical risk assessment tool demonstrates a 10-year fracture risk equal to or greater than that of a 65-year-old white woman with no additional risk factors (≥ 8.4%).
Estimated Time:1m 30s
Rate this question

Topics

Preventive Care and Screening

More questions from this topic